NR1D1 and neuroblastoma: By comprehensive analysis of 3576 altered genes in RNA‐seq assay and 1637 genes with RORB enrichment peak in ChIP‐seq assay, 174 potential RORB target genes were identified, while 34 of which showed significant correlation with clinical outcomes in a cohort of 498 (GSE62564) NB patients (Figure 2C), including top ranking ones involved in regulation of NF‐κB signaling pathway, such as NR1D1 and RIOK3 (Figure 2D,E).